Symbia

Early-stage AI platform that automates Investigational New Drug preparation, generating pre-IND packets and CTD submodules.

Symbia, founded in 2024 and headquartered in San Francisco, California, is an early-stage (Y Combinator) company that automates the preparation of Investigational New Drug (IND) applications, importing source documents and generating pre-IND packets and Common Technical Document (CTD) submodules through an interactive review interface. As a pre-seed company, its scale and enterprise readiness should be assessed directly. Atlas found no vendor-held security certifications documented on its site; generated documents require regulatory-team review before submission.

Headquarters
San Francisco, United States
Founded
2024
Deployment options
cloud
Website
https://symbia.ai
LinkedIn
https://www.linkedin.com/company/atomdotcom

Categories

AI Use Cases

  • Regulatory Submission Authoring

Vendor Scorecard

50% — Partial coverage. Coverage score — how completely Atlas documents Symbia across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Not documented by Atlas

Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?

Deployment & Hosting — Documented

cloud

Pricing Transparency — Not documented by Atlas

Ask the vendor: What is your pricing model, and what drives total cost of ownership?

Implementation & Onboarding — Not documented by Atlas

Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?

Organization & Role Fit — Documented

Biotech Startup, Mid-Size Biotech, Regulatory Affairs

Solution Scope — Documented

Regulatory Submission Authoring

Company Viability — Partially documented

Pre-seed, Founded 2024

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • Which CTD submodules and submission types are supported in production today?
  • How does the review workflow document human accountability for generated content?
  • How is our proprietary source data protected during import and generation?
  • What is the company's funding runway and enterprise-support model?